2025 International Congress » Parkinson's disease: Neuroimaging

Meeting: 2025 International Congress

A novel potential imaging biomarker for Parkinson’s disease: Optical Coherence Tomography.

G. Napoli, R. Santangelo, G. Rugarli, R. Balestrino, E. Sarasso, L. Ferini-Strambi, M. Filippi, F. Agosta (Milan, Italy)

Apolipoprotein E ɛ4-allele and Amygdala Atrophy in Parkinson’s Disease: A Preliminary Longitudinal Analysis from the ONDRI Cohort

U. Saeed, R. Bartha, M. Binns, S. Black, D. Grimes, R. Hegele, C. Marras, . Rogaeva, M. Lang, M. Masellis (Toronto, Canada)

Bayesian Re-Analysis of Phase I and II Subthalamic Nucleus Perfusion Changes Following Mesenchymal Stem Cell Infusion in Parkinson’s Disease

T. Thomas, T. Ellmore, E. Tharp, J. Martinez-Lemus, C. Green, J. Suescun, C. Onuigbo, T. Le, E. Rodarte Rascon, R. Ritter Iii, M. Schiess (Houston, USA)

Brain Energetics: Changes in Healthy Aging and Parkinson’s Disease

C. Bevington, S. Dhaliwal, J. Mckenzie, A. Stoessl, V. Sossi (Vancouver, Canada)

Brain hemodynamic responses to a motor control paradigm in younger and older adults, and people with Parkinson’s Disease: An fNIRS mediated feasibility study.

M. Bjalme-Evans, K. Heffernan, D. Wani, S. Leung, J. Carter, A. Bowden, A. Raghunathan, L. Quinn (New York, USA)

Cerebello-Thalamo-Cortical Tract Microstructural Changes in Parkinson’s Disease Patients with Tremor

I. Cruz, M. Wilken, G. álvarez, M. Villarreal, M. Merello (Buenos Aires, Argentina)

Cerebral Glucose Metabolic Features of GBA-Parkinson’s Disease as a window into cognitive impairment

P. Mitrotti, R. Calabrese, M. Picascia, L. Gallo, R. Malito, A. Panzacchi, C. Galandra, M. Todisco, R. Zangaglia, D. Perani, A. Chiti, EM. Valente, C. Tassorelli, S. Camminiti, M. Avenali (Pavia, Italy)

Cholinergic activity associates with cognitive function in PD using [18F]VAT

J. O'Donnell, A. Eid, H. Hwang, S. Grossen, J. Hood, E. Foster, Z. Tu, J. Perlmutter, M. Campbell (St. Louis, USA)

Clinical And Cerebellar Structural Alterations In Parkinson’s Disease Patients With Freezing Of Gait

E. Sarasso, A. Gardoni, A. Grassi, L. Zenere, S. Basaia, G. Bonardi, S. Carta, I. Di Vico, E. Mantovani, E. Canu, M. Bressan, V. Castelnovo, E. Sibilla, C. Tripodi, F. Freri, R. Balestrino, M. Trentinaglia, F. Maffei, V. Chiodega, S. Tamburin, MA. Volontè, S. Mariotto, M. Tinazzi, M. Filippi, F. Agosta (Milan, Italy)

Clinical Profile and 18F -Fluorodopa Positron Emission Tomography (18F -DOPA PET) Findings in a Movement Disorder Clinic Patient Cohort

S. Yellaturi, M. Prabhu, A. Behera, S. Pandey (Faridabad, India)

Combining Pharmaceutical and Digital Treatment Approaches in Parkinson’s Disease Modulates of the Limbic System, Supporting Emotional Regulation and Motivated Behaviors

N. Saporta, M. Catalogna, T. Tamir, R. Sivan Hoffmann, A. Amedi (Ramat Gan, Israel)

Comparison of MIBG Uptake in the Major Salivary Glands Between Rapid Eye Movement Sleep Behavior Disorder and Parkinson’s Disease

J. Ebina, S. Mizumura, M. Shibukawa, J. Nagasawa, T. Hirayama, N. Ishii, Y. Kobayashi, A. Inaba, S. Orimo, O. Kano (Tokyo, Japan)

Comparison of Microglial PET Imaging in Parkinson’s Disease, RBD, and Controls with a CSF1R and TSPO Ligand.

K. Mills, I. Cheong, Y. Du, J. Coughlin, A. Horti, C. Motley, R. Dannals, W. Lesniak, T. Dawson, M. Pomper (Baltimore, USA)

Decoding Parkinson’s Progression: Longitudinal Volumetric MRI Biomarkers in Prodromal and Clinical Stages

S. Datta, M. Acharya, N. Ghosh, B. Chakraborty (Kharagpur, India)

Decreased cholinergic activity in specific brain regions associated with slower lower limb visual choice reaction time in Parkinson’s disease: A [18F]-FEOBV PET study

P. Kanel, G. Carli, J. Barr, F. Michalakis, S. Roytman, R. Vangel, P. Scott, C. Pongmala, R. Albin, N. Bohnen (Ann. Arbor, USA)

Decreased DTI-ALPS Indices and their Association with Clinical Features in Parkinson’s Disease

J. Pardo, I. Roura, C. Martín-Barceló, C. Falcon, R. Sala-Llonch, J. Oltra, A. Campabadal, N. Bargalló, MA. Jurado, M. Garolera, MJ. Martí, Y. Compta, C. Junqué, B. Segura (Barcelona, Spain)

Detection and classification of Parkinson’s disease from neuroimaging modalities using machine learning and artificial intelligence: a systematic review

F. Ebrahimian Sadabad, P. Honhar, S. Houshi, F. Nejati, S. Bagherieh, A. Brackett, F. Yazdanpanah, S. Cayir, M. Hosseini, H. Tagare, D. Matuskey (New Haven, USA)

Diffusion MRI Changes Linked to α-Synuclein Seed Amplification Status in Parkinson’s Disease

S. Chiu, W. Wang, R. Chen, J. Desimone, C. Adler, S. Mehta, S. Dresler, N. Mcfarland, M. Okun, D. Vaillancourt (Scottsdale, USA)

Dopamine Transporter Imaging as a Predictor of Functional Outcomes in Parkinson’s Disease

K. Niemi, V. Kaasinen, J. Joutsa (Turku, Finland)

Dopaminergic and Synaptic Alterations in SWEDD: Insights from [¹⁸F] FE-PE2I and [¹¹C] UCB-J PET Imaging

F. Ebrahimian Sadabad, T. Volpi, P. Honhar, L. Colon, S. Tinaz, M. Naganawa, M. Dias, G. Angarita, R. Comley, R. Carson, S. Finnema, D. Matuskey (Tallahassee, USA)

Dual task elicited premotor and supplementary motor activity as sensitive markers of mild Parkinson’s disease: an fNIRS analysis

J. Longhurst, S. Conklin, Y. Chiu (Saint Louis, USA)

Effect of Exercise Intervention on Parkinson’s Disease Resting-State fMRI Functional Connectivity

E. Reimers, C. Bevington, J. Mckenzie, S. Dhaliwal, J. Stoessl, V. Sossi (Vancouver, Canada)

Evaluation of Perfusion, Iron Deposition, and Neuromelanin MRI Biomarkers Following Mesenchymal Stem Cell Treatment in a Phase 2 Parkinson’s Disease Trial

J. Martinez-Lemus, E. Tharp, T. Ellmore, T. Thomas, C. Green, J. Suescun, C. Onuigbo, T. Le, E. Rodarte-Rascon, R. Ritter Iii, M. Schiess (Houston, USA)

Evaluation of swallow tail sign on 1.5 Tesla Magnetic Resonance Imaging in Parkinson´s disease patients in a tertiary hospital

E. Vioncek, M. Ferreira Cordellini, L. Kami, B. Teixeira (Curitiba, Brazil)

Exploring local gyrification index to understand Parkinson’s disease with mild cognitive impairment

N. Chaurasiya, A. Katragadda, G. Rathi, J. Caldwell, Z. Mari, V. Mishra (Birmingham, USA)

Exploring the Association between Autonomic Responses and Dopaminergic Pathways in Early Parkinson’s Disease

E. Garasto, A. Stefani, M. Pierantozzi, N. Mercuri, A. Chiaravalloti, C. Rocchi (Rome, Italy)

Functional Segregation in Parkinson’s Disease

DN. Su, J. Hanania, A. Pavel, M. Matarazzo, J. Mckenzie, J. Cheng, N. Vafai, S. Dhaliwal, V. Sossi, A. Stoessl (Beijing, China)

Gray Matter Microstructural Integrity in Relation to Frontostriatal and Posterior Cortical Cognitive Performance in Parkinson’s Disease

Q. Devignes, M. Egan, A. Kayris, S. Peltier, B. Hampstead, L. Hernandez-Garcia (Ann Arbor, USA)

Hippocampal-striatal interaction and cognitive decline in Parkinson’s disease with mild cognitive impairment

S. Tan, X. Zhang, J. Wen, X. Xu, Z. Zhang, J. Xu (Hangzhou, China)

Identification of Distinctive Iron Deposition Pattern in Subcortical Nuclei of Parkinson’s Disease using Radiomics: A 7T Susceptibility-Weighted Imaging Study

T. Feng, DN. Su, SD. Ding, ZJ. Zhang, Z. Zhang, J. Jing (Beijing, China)

Identifying Cut-off Values, Effects of AD Co-pathology, Sex Differences, and Temporal Changes of 123I-FP-CIT SPECT in Autopsy-proven LBD

T. Miyagawa, S. Przybelski, C. Cynthia, HK. Minmin, L. Forsberg, J. Fields, S. Mccarter, T. Ferman, V. Ramanan, J. Graff-Radford, D. Jones, R. Savica, D. Knopman, R. Petersen, R. Reichard, A. Nguyen, D. Dickson, M. Murray, G. Day, N. Graff-Radford, C. Lachner, E. St Louis, M. Jain, K. Kantarci, V. Lowe, B. Boeve (ROCHESTER, USA)

Impact of Aquaporin-4 polymorphisms on Glymphatic Function and Motor Symptoms in Parkinson’s Disease

J. Qin, M. Zhang (Hangzhou, China)

Impact of Patient-Specific Structural Connectivity of STN-DBS on Balance and Mobility – Pilot study

š. Janovič, S. Holly, M. Chmelík, D. Juskanič, L. Pátrovič, A. Kušnírová, Z. Košutzká (Bratislava, Slovakia)

Impaired Speech Perception in Noise (SPiN), Hearing Loss, and Cholinergic Denervation in Parkinson’s Disease

S. Roytman, D. Mccaslin, J. Barr, R. Vangel, P. Kanel, N. Bohnen (Ann. Arbor, USA)

Improving Motor and Non-motor Symptoms in Parkinson’s Disease: A combined Pharmaceutical and Digital Approach Targeting Parallel Neural Circuits

A. Amedi, N. Saporta, T. Tamir, R. Sivan Hoffmann, M. Catalogna (Herzliya, Israel)

Levodopa mediated normalization of cerebello-thalamo-cortical GABA and Glutamate in Parkinson’s disease

S. Prasad, D. Deelchand, M. Kumar, R. Yadav, P. Pal, J. Saini (Bengaluru, India)

Longitudinal Brain Morphometric Trajectories Across Parkinson Disease Clinical Subtypes

A. Eid, S. Grossen, A. Tanenbaum, J. Hood, H. Hwang, T. Cash, C. Lessov-Schlaggar, J. Jackson, P. Kotzbauer, J. Perlmutter, M. Campbell (Saint Louis, USA)

Longitudinal Effects of Initial Deep Brain Stimulation Settings on Force-Tracking Brain Activation and Motor Performance in Parkinson’s Disease

A. Vijayakumari, C. Piccinin, T. Lopez Gonzalez, J. Alberts, P. Bhattacharyya, M. Lowe, B. Walter (Cleveland, USA)

Longitudinal MRI Study of Hippocampal Subfields Morphometry in Early Parkinson’s Disease

T. Wu, S. Ng, T. Teo, X. Choi, D. Heng, S. Neo, Z. Xu, K. Tay, W. Au, E. Tan, L. Chan, L. Tan, T. Welton (Singapore, Singapore)

Metabolic Imaging Correlates of Apathy in Parkinson’s Disease.

J. Arena, M. Ponce-de-Leon, L. Fiorentini, C. Obarrio, S. Vazquez, Y. Bergamo, M. Merello (Buenos Aires, Argentina)

Metabolic network signature of quantitative motor effects following deep brain stimulation in Parkinson’s disease

A. Calvano, A. Turan, U. Kleinholdermann, V. Heinecke, K. Steidel, L. Ruesing, F. Thiemig, D. Librizzi, T. Schurrat, M. Beckersjuergen, M. Luster, L. Timmermann, C. Eggers, M. Ruppert-Junck, D. Pedrosa (Marburg, Germany)

MultiModal Transformer-Based Detection of Parkinson’s Disease in fMRI Extracted Time Series

S. Patel, C. Antoniades, J. Fitzgerald, O. Bredemeyer (Oxford, United Kingdom)

Multiparametric Prediction of Mild Cognitive Impairment in Parkinson’s Disease Using a Combination of Structural and Functional MRI Measures

G. Rathi, T. Davis, J. Caldwell, Z. Mari, V. Mishra (Birmingham, USA)

Neural Correlates of Rhythmic Auditory Stimulation Responsiveness in Parkinson’s Disease: A Pilot Gait and fMRI Study

CY. Chien, CL. Lin, JSK. Chang, YH. Liu, SC. Wang, CC. Lin (Tainan, Taiwan)

Predicting the Cognitive-Psychiatric Phenotype of Parkinson’s Disease

H. Dhanis, J. Potheegadoo, S. Stampacchia, F. Bernasconi, C. Stucker, M. Maradan, L. Thanh, L. Jenni, J-A. Ghika, P. Burkhard, B. Vicki, D. Benninger, J. Horvath, P. Krack, D. de Ville, O. Blanke (Bern, Switzerland)

Predictors of Рostural Instability and Gait Disturbances after STN-DBS in Parkinson’s Disease

O. Alenikova, A. Chumak, L. Parhach, N. Alenikov (Minsk, Belarus)

Prevalence and Clinical Characteristics of iNPH-Related Imaging Findings (DESH) in Parkinson’s Disease

T. Baba, T. Totsune, T. Nakamura, Y. Sugimura, H. Oizumi, H. Tanaka, T. Takahashi, M. Yoshioka, K. Nagamatsu, T. Hasegawa, A. Takeda (Sendai, Japan)

Prospective Tractography-Guided STN DBS Targeting with Optimized vmPFC Connectivity for Apathy in PD a Case Report

J. de Bruin, K S. Choi, J. Jimenez-Shahed, B. Kopell, H. Mayberg, M. Figee (New York, USA)

Robust Computation of Subcortical Functional Connectivity Guided by Quantitative Susceptibility Mapping: An Application in Parkinson’s Disease Diagnosis

J. Qin, C. He, Y. Ma, X. Guan, M. Zhang (Hangzhou, China)

Scans Without Evidence of Dopamine Deficiency (SWEDD) in Early-Onset Parkinson’s Disease: Comprehensive Clinical Analysis

A. Zare Dehnavi, C. Piat, A. Mullan, P. Turcano, E. Camerucci, M. Derhab, R. Savica (Rochester, USA)

Seed-based Metabolic Networks and Time Series Variation based on Functional [18F]-FDG PET in Parkinson’s Disease

M. Ruppert-Junck, V. Heinecke, K. Steidel, L. Rüsing, F. Thiemig, D. Librizzi, T. Schurrat, M. Beckersjürgen, J. Fuchs, H. Müller, M. Luster, L. Timmermann, C. Eggers, D. Pedrosa (Marburg, Germany)

Semi-quantitative Evaluation of Midbrain Accumulation in 123I-FP-CIT SPECT in Parkinson’s disease and Parkinsonian Syndromes

T. Totsune, T. Baba, Y. Sugimura, H. Oizumi, H. Tanaka, T. Takahashi, M. Yoshioka, K. Nagamatsu, T. Hasegawa, A. Takeda (Sendai, Japan)

Sensory-motor striatum iron accumulation in patients with isolated rapid eye movement sleep behavior disorder and its correlation with processing speed performance

C. Garcia-Vicente, I. Roura, J. Pardo, C. Martín-Barceló, C. Falcon, R. Sala-Llonch, N. Bargalló, M. Serradell, C. Gaig, G. Mayà, A. Montini, C. Junqué, A. Iranzo, B. Segura (Madrid, Spain)

STN Iron Content Correlates with DBS Efficacy in Parkinson’s Patients: a Preliminary Study

G. Du, A. Snyder, J. Seemiller, L. Kong, P. Eslinger, J. Mcinerney, E. Farace, R. Mailman, X. Huang, S. de Jesus (Hersehy, USA)

Striatal dopamine- and basal forebrain cholinergic-dependent brain metabolism and cognition in Parkinson’s disease

HS. Yoo, JH. Lee, M. Park, SJ. Ahn, JH. Lee, YH. Ryu, CH. Lyoo (Seoul, Republic of Korea)

Striatal Dysfunction in Parkinson’s Disease Progression: A 18F-9-fluoropropyl-(+)-dihydrotetrabenazine(18F-AV133) PET Study

X. Liu, G. Tamagnan, H. Qiao, J. Lu, C. Zhang, S. Liu (Beijing, China)

Sub-grouping of Parkinson’s disease based on thalamic subnuclei volume

S. Haji, W. Sako, H. Haginiwa, K. Kamagata, T. Hatano, N. Hattori (Bunkyo, Japan)

Subthalamic nucleus DBS outcomes correlate with white matter tractography in Parkinson’s Disease

I. Campbell, V. Del Bene, R. Martin, C. Gonzalez, S. Brinkerhoff, M. Wade, B. Hill, H. Walker, V. Mishra (Mobile, USA)

The Associations between Cognitive Reserve Proxies, Multimodal MRI Brain Measures and Cognition, Motor Function and Mood in Parkinson’s Disease

I. Saywell, S. Sghirripa, A. Walls, A. Dwyer, B. Child, J. Salamon, S. Hansch-Maher, L. Collins-Praino, M. Jenkinson, I. Baetu (Adelaide, Australia)

Theta-Burst Subthalamic Nucleus Deep Brain Stimulation Enhances Segregation of Cognitive Networks in Parkinson’s Disease

M. Abu-Zahra, S. Audrain, A. Barnett, K. Wu, W. Choi, K. Jann, C. Mark, R. Briggs, J. Cavaleri, B. Lee, X. Mason, D. Lee (Montreal, Canada)

Transcranial sonography in Parkinson’s disease patients

D. Khasanova, I. Khasanov, Z. Zalyalova (Kazan, Russian Federation)

Uncovering the heterogeneity of spatiotemporal trajectories of neurodegeneration in Parkinson’s disease: an early-phase 18F-FP-CIT PET study

SJ. Chung, J. Lee, Y. Choi, J. Jang, HK. Na, PH. Lee (Seoul, Republic of Korea)